Boosting immune response with a candidate varicella-zoster virus glycoprotein subunit vaccine

By Vafai A.  

Vaccine, Vol. 13, Iss. 14, 1995-10 ,pp. : 1336-1338

Elsevier

Access to resources Recommend Favorite

Induction of neutralizing antibody and T-cell responses to Varicella-zoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoprotein E (gE)

By Garcia-Valcarcel M.   Fowler W.J.   Harper D.R.   Jeffries D.J.   Layton G.T.  

Vaccine, Vol. 15, Iss. 6, 1997-04 ,pp. : 709-719

Elsevier

Access to resources Recommend Favorite

Immunization with a DNA vaccine expressing a truncated form of varicella zoster virus glycoprotein E

By Hasan U.A.   Harper D.R.   Wren B.W.   Morrow W.J.W.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1308-1315

Elsevier

Access to resources Recommend Favorite

Seroprevalence of varicella-zoster virus in the German population

By Wutzler P.   Farber I.   Wagenpfeil S.   Bisanz H.   Tischer A.  

Vaccine, Vol. 20, Iss. 1, 2001-10 ,pp. : 121-124

Elsevier

Access to resources Recommend Favorite

Immunization with a DNA expression vector encoding the varicella zoster virus glycoprotein E (gE) gene via intramuscular and subcutaneous routes

By Hasan U.A.   Harper D.R.   Argent S.   Layton G.   Wren B.W.   Morrow W.J.W.  

Vaccine, Vol. 18, Iss. 15, 2000-02 ,pp. : 1506-1514

Elsevier

Access to resources Recommend Favorite